Matches in SemOpenAlex for { <https://semopenalex.org/work/W4302211607> ?p ?o ?g. }
Showing items 1 to 77 of
77
with 100 items per page.
- W4302211607 endingPage "8" @default.
- W4302211607 startingPage "1645" @default.
- W4302211607 abstract "The cutaneous toxicities of epidermal growth factor receptor(EGFR)inhibitors including cetuximab, gefitinib and erlotinib, and multi-kinase inhibitors including imatinib mesylate, sorafenib, and sunitinib, are described. Acneiform eruption, paronychia and xerosis are common cutaneous toxicities in patients receiving EGFR inhibitors. Acneiform eruption usually consists of follicular papules and pustules without comedones and is observed in more than 50% patients. Paronychia occurs less frequently(10 approximately 15%)than acneiform eruption and involves multiple fingers and great toes. Xerosis is observed in 35% of patients. Painful fissures on the tips of fingers and toes can also develop because of excessive dry skin. Concerning multi-kinase inhibitors, pigmentary disorders and periorbital edema occur frequently during imatinib therapy, and hand foot skin reaction is observed by sorafenib or sunitinib. The hand foot skin reaction is clinically somewhat similar to acral erythema(hand foot syndrome)seen with docetaxel and other classic chemotherapy agents in that the lesions seem to be more discrete and hyperkeratotic. Subungual splinter hemorrhages have also been reported in 60% of patients receiving sorafenib and in 30% of patients receiving sunitinib. Although the mechanism of these cutaneous toxicities has not been fully elucidated, they are suspected to be caused by these molecularly targeted drugsc own actions. Therefore, the presence of these cutaneous toxicities may serve as a surrogate marker of treatment efficacy and a predictor of survival." @default.
- W4302211607 created "2022-10-06" @default.
- W4302211607 creator A5033764996 @default.
- W4302211607 creator A5083641551 @default.
- W4302211607 date "2008-10-01" @default.
- W4302211607 modified "2023-09-29" @default.
- W4302211607 title "[Cutaneous toxicities]." @default.
- W4302211607 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18931563" @default.
- W4302211607 hasPublicationYear "2008" @default.
- W4302211607 type Work @default.
- W4302211607 citedByCount "1" @default.
- W4302211607 countsByYear W43022116072022 @default.
- W4302211607 crossrefType "journal-article" @default.
- W4302211607 hasAuthorship W4302211607A5033764996 @default.
- W4302211607 hasAuthorship W4302211607A5083641551 @default.
- W4302211607 hasConcept C121608353 @default.
- W4302211607 hasConcept C126322002 @default.
- W4302211607 hasConcept C143998085 @default.
- W4302211607 hasConcept C16005928 @default.
- W4302211607 hasConcept C2776694085 @default.
- W4302211607 hasConcept C2777506169 @default.
- W4302211607 hasConcept C2778019345 @default.
- W4302211607 hasConcept C2778087573 @default.
- W4302211607 hasConcept C2778169587 @default.
- W4302211607 hasConcept C2778695046 @default.
- W4302211607 hasConcept C2779121184 @default.
- W4302211607 hasConcept C2779438470 @default.
- W4302211607 hasConcept C2779490328 @default.
- W4302211607 hasConcept C2779515644 @default.
- W4302211607 hasConcept C2779998722 @default.
- W4302211607 hasConcept C2780035454 @default.
- W4302211607 hasConcept C2780580887 @default.
- W4302211607 hasConcept C2781190966 @default.
- W4302211607 hasConcept C526805850 @default.
- W4302211607 hasConcept C71924100 @default.
- W4302211607 hasConcept C98274493 @default.
- W4302211607 hasConceptScore W4302211607C121608353 @default.
- W4302211607 hasConceptScore W4302211607C126322002 @default.
- W4302211607 hasConceptScore W4302211607C143998085 @default.
- W4302211607 hasConceptScore W4302211607C16005928 @default.
- W4302211607 hasConceptScore W4302211607C2776694085 @default.
- W4302211607 hasConceptScore W4302211607C2777506169 @default.
- W4302211607 hasConceptScore W4302211607C2778019345 @default.
- W4302211607 hasConceptScore W4302211607C2778087573 @default.
- W4302211607 hasConceptScore W4302211607C2778169587 @default.
- W4302211607 hasConceptScore W4302211607C2778695046 @default.
- W4302211607 hasConceptScore W4302211607C2779121184 @default.
- W4302211607 hasConceptScore W4302211607C2779438470 @default.
- W4302211607 hasConceptScore W4302211607C2779490328 @default.
- W4302211607 hasConceptScore W4302211607C2779515644 @default.
- W4302211607 hasConceptScore W4302211607C2779998722 @default.
- W4302211607 hasConceptScore W4302211607C2780035454 @default.
- W4302211607 hasConceptScore W4302211607C2780580887 @default.
- W4302211607 hasConceptScore W4302211607C2781190966 @default.
- W4302211607 hasConceptScore W4302211607C526805850 @default.
- W4302211607 hasConceptScore W4302211607C71924100 @default.
- W4302211607 hasConceptScore W4302211607C98274493 @default.
- W4302211607 hasIssue "10" @default.
- W4302211607 hasLocation W43022116071 @default.
- W4302211607 hasOpenAccess W4302211607 @default.
- W4302211607 hasPrimaryLocation W43022116071 @default.
- W4302211607 hasRelatedWork W1976155116 @default.
- W4302211607 hasRelatedWork W1998085563 @default.
- W4302211607 hasRelatedWork W2004350020 @default.
- W4302211607 hasRelatedWork W2023373067 @default.
- W4302211607 hasRelatedWork W2038504383 @default.
- W4302211607 hasRelatedWork W2064198754 @default.
- W4302211607 hasRelatedWork W2172886181 @default.
- W4302211607 hasRelatedWork W2380392281 @default.
- W4302211607 hasRelatedWork W62942737 @default.
- W4302211607 hasRelatedWork W2144102646 @default.
- W4302211607 hasVolume "35" @default.
- W4302211607 isParatext "false" @default.
- W4302211607 isRetracted "false" @default.
- W4302211607 workType "article" @default.